These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17715379)

  • 21. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway inflammation in chronic obstructive pulmonary disease.
    Górska K; Maskey-Warzechowska M; Krenke R
    Curr Opin Pulm Med; 2010 Mar; 16(2):89-96. PubMed ID: 19904205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local inflammation occurs before systemic inflammation in patients with COPD.
    He Z; Chen Y; Chen P; Wu G; Cai S
    Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
    Sutherland ER; Martin RJ
    J Allergy Clin Immunol; 2003 Nov; 112(5):819-27; quiz 828. PubMed ID: 14610463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.
    Antoniu SA
    Biomarkers; 2010 Mar; 15(2):97-103. PubMed ID: 19929747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model rats.
    Onoue S; Aoki Y; Matsui T; Kojo Y; Misaka S; Mizumoto T; Yamada S
    Int J Pharm; 2011 May; 410(1-2):54-60. PubMed ID: 21419198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Airway nitrergic pathways: is there therapeutic potential in asthma and COPD?
    Folkerts G; Nijkamp FP
    Curr Opin Pharmacol; 2004 Jun; 4(3):202-6. PubMed ID: 15140409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
    Beeh KM; Beier J
    Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute exacerbation of COPD].
    Bals R; Becker HF; Wagner U; Vogelmeier C
    Pneumologie; 2006 Jan; 60(1):11-23; quiz 24-5. PubMed ID: 16429389
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacological treatment of COPD. Where are we now?].
    Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment.
    Mroz RM; Holownia A; Chyczewska E; Braszko JJ
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease.
    Man SF; Sin DD
    Proc Am Thorac Soc; 2005; 2(1):78-82. PubMed ID: 16113473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Innervation of the airways in asthma bronchiale and chronic obstructive pulmonary disease (COPD)].
    Dinh QT; Suhling H; Fischer A; Braun A; Welte T
    Pneumologie; 2011 May; 65(5):283-92. PubMed ID: 21271508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histone dependent signalization during pharmacotherapy of chronic obstructive pulmonary disease].
    Mróz RM; Noparlik J; Chyczewska E; Braszko JJ; Hołownia A
    Pneumonol Alergol Pol; 2007; 75(4):375-82. PubMed ID: 18080988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nature of small-airway obstruction in chronic obstructive pulmonary disease.
    Hogg JC; Chu F; Utokaparch S; Woods R; Elliott WM; Buzatu L; Cherniack RM; Rogers RM; Sciurba FC; Coxson HO; Paré PD
    N Engl J Med; 2004 Jun; 350(26):2645-53. PubMed ID: 15215480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment and prevention of COPD exacerbation].
    Yamaya M; Yasuda H; Yoshida M; Nishimura H; Nakayama K
    Nihon Rinsho; 2007 Apr; 65(4):734-9. PubMed ID: 17419396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal.
    Contoli M; Bousquet J; Fabbri LM; Magnussen H; Rabe KF; Siafakas NM; Hamid Q; Kraft M
    Allergy; 2010 Feb; 65(2):141-51. PubMed ID: 19909298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment in asthma and COPD.
    Hoshino T; Toda R; Aizawa H
    Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budesonide inhibits interleukin-32 expression in a rat model of chronic obstructive pulmonary disease.
    Deng X; Zhang Z; Gu W; Li Y; Liu M
    Exp Lung Res; 2012 Aug; 38(6):295-301. PubMed ID: 22646473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.